FDA Inspection 1100923 — Glenmark Pharmaceuticals Ltd.
The FDA completed an inspection of Glenmark Pharmaceuticals Ltd. on Jun 6, 2019 in Navi Mumbai. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 6, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Navi Mumbai (India)
Additional Details
Clinical BA/BE